Gene · 51592
Papers2,289
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,289
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
The Pattern and Progression of "Usual" Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis. | J Clin Med | 2024 | 38256503 | PubTator, text mining | PubMed |
| Upadacitinib therapy in refractory inflammatory myositis: a case series of 10 patients. | RMD Open | 2024 | 38242552 | PubTator, text mining | PubMed |
| Unraveling the mystery of fever of unknown origin: a remarkable journey towards the diagnosis of peripheral T-cell lymphoma-T follicular helper type: A rare case report. | Medicine (Baltimore) | 2024 | 38241538 | PubTator, text mining | PubMed |
| Mixed connective tissue and ovarian cancer: a case report. | Ann Med Surg (Lond) | 2024 | 38222766 | PubTator, text mining | PubMed |
| Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases. | Acta Neuropathol | 2024 | 38214778 | PubTator, text mining | PubMed |
| Deep RNA sequencing of muscle tissue reveals absence of viral signatures in dermatomyositis. | Free Neuropathol | 2024 | 38205217 | PubTator, text mining | PubMed |
| Severe gastrointestinal involvements in patients with adult dermatomyositis with anti-NXP2 antibody. | RMD Open | 2024 | 38199847 | PubTator, text mining | PubMed |
| Two cases of dermatomyositis associated with neuroendocrine tumors. | Int Cancer Conf J | 2024 | 38187177 | PubTator, text mining | PubMed |
| Clinicopathological Reclassification of Idiopathic Inflammatory Myopathy to Match the Serological Results of Myositis-Specific Antibodies. | J Clin Neurol | 2024 | 38179634 | PubTator, text mining | PubMed |
| Possible correlation between serum interleukin-8 levels and the activity of myositis in anti-NXP2 antibody-positive dermatomyositis. | Immunol Med | 2024 | 38174692 | PubTator, text mining | PubMed |
| Simulation and Computational Study of RING Domain Mutants of BRCA1 and Ube2k in AD/PD Pathophysiology. | Mol Biotechnol | 2024 | 38172369 | PubTator, text mining | PubMed |
| Refractory dermatomyositis responsive to anifrolumab. | JAAD Case Rep | 2024 | 38162409 | PubTator, text mining | PubMed |
| Anti-PL-7, anti-Ro/SSA, anti-Mi-2, and anti-TIF1-γ correlate with specific patterns of histopathologic features in dermatomyositis: An analysis of 39 skin biopsy specimens from 25 patients. | J Cutan Pathol | 2024 | 38158735 | PubTator, text mining | PubMed |
| Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies. | J Neuromuscul Dis | 2024 | 38143369 | PubTator, text mining | PubMed |
| Clinical Features and Immunogenetic Risk Factors Associated With Additional Autoantibodies in Anti-Transcriptional Intermediary Factor 1γ Juvenile-Onset Dermatomyositis. | Arthritis Rheumatol | 2024 | 38059274 | PubTator, text mining | PubMed |
| Comprehensive analysis of the proximity-dependent nuclear interactome for the oncoprotein NOTCH1 in live cells. | J Biol Chem | 2024 | 38043798 | PubTator, text mining | PubMed |
| Activation of immune evasion machinery is a part of the process of malignant transformation of human cells. | Transl Oncol | 2024 | 37844478 | PubTator, text mining | PubMed |
| Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry. | Rheumatology (Oxford) | 2024 | 37698987 | PubTator, text mining | PubMed |
| Anti-TIF-1γ Positive Juvenile Dermatomyositis Diagnosed with Atopic Dermatitis. | Indian J Pediatr | 2024 | 37651063 | PubTator, text mining | PubMed |
| Vasculopathy in dermatomyositis. | Chin Med J (Engl) | 2024 | 37415507 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51592/papers?page=12